BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11530441)

  • 21. [Excluded patient group. A new approach is necessary for adults with ADHD/Tourette syndrome/autism spectrum disorders].
    Bejerot S
    Lakartidningen; 2006 May 10-16; 103(19):1508. PubMed ID: 16805246
    [No Abstract]   [Full Text] [Related]  

  • 22. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update.
    Prince J
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S39-45. PubMed ID: 18480676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A direct prefrontotectal tract against distractibility in the human brain.
    Gaymard B; François C; Ploner CJ; Condy C; Rivaud-Péchoux S
    Ann Neurol; 2003 Apr; 53(4):542-5. PubMed ID: 12666125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-regulation of slow cortical potentials: a new treatment for children with attention-deficit/hyperactivity disorder.
    Strehl U; Leins U; Goth G; Klinger C; Hinterberger T; Birbaumer N
    Pediatrics; 2006 Nov; 118(5):e1530-40. PubMed ID: 17060480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New potential leads in the biology and treatment of attention deficit-hyperactivity disorder.
    Casey BJ; Nigg JT; Durston S
    Curr Opin Neurol; 2007 Apr; 20(2):119-24. PubMed ID: 17351480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions.
    Arnsten AF; Li BM
    Biol Psychiatry; 2005 Jun; 57(11):1377-84. PubMed ID: 15950011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shared and disorder-specific prefrontal abnormalities in boys with pure attention-deficit/hyperactivity disorder compared to boys with pure CD during interference inhibition and attention allocation.
    Rubia K; Halari R; Smith AB; Mohammad M; Scott S; Brammer MJ
    J Child Psychol Psychiatry; 2009 Jun; 50(6):669-78. PubMed ID: 19236528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repetitive Transcranial Magnetic Stimulation of the Supplementary Motor Area in the treatment of Tourette Syndrome: report of two cases.
    Mantovani A; Leckman JF; Grantz H; King RA; Sporn AL; Lisanby SH
    Clin Neurophysiol; 2007 Oct; 118(10):2314-5. PubMed ID: 17709291
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comorbid disorders of the attention deficit with hyperactivity disorder].
    Pascual-Castroviejo I
    Rev Neurol; 2002 Jul 1-15; 35(1):11-7. PubMed ID: 12389186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Structural magnetic resonance imaging findings as an aid to explain the neurobiology of attention deficit hyperactivity disorder: towards the identification of a neuroanatomical phenotype].
    Soliva-Vila JC; Vilarroya-Oliver O
    Rev Neurol; 2009 Jun 1-15; 48(11):592-8. PubMed ID: 19472158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dorsolateral prefrontal and anterior cingulate cortex volumetric abnormalities in adults with attention-deficit/hyperactivity disorder identified by magnetic resonance imaging.
    Seidman LJ; Valera EM; Makris N; Monuteaux MC; Boriel DL; Kelkar K; Kennedy DN; Caviness VS; Bush G; Aleardi M; Faraone SV; Biederman J
    Biol Psychiatry; 2006 Nov; 60(10):1071-80. PubMed ID: 16876137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Motor cortex inhibitory function in Tourette syndrome, attention deficit disorder, and obsessive compulsive disorder: studies using transcranial magnetic stimulation.
    Gilbert DL
    Adv Neurol; 2006; 99():107-14. PubMed ID: 16536356
    [No Abstract]   [Full Text] [Related]  

  • 33. The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis.
    Dickstein SG; Bannon K; Castellanos FX; Milham MP
    J Child Psychol Psychiatry; 2006 Oct; 47(10):1051-62. PubMed ID: 17073984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neural substrates of attention-deficit hyperactivity disorder.
    Castellanos FX
    Adv Neurol; 2001; 85():197-206. PubMed ID: 11530428
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical aspects of Tourette syndrome].
    Debes NM; Hjalgrim H; Skov L
    Ugeskr Laeger; 2008 Aug; 170(35):2701-3. PubMed ID: 18761861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of DRD4 and DAT1 genotype on fronto-striatal gray matter volumes in a sample of subjects with attention deficit hyperactivity disorder, their unaffected siblings, and controls.
    Durston S; Fossella JA; Casey BJ; Hulshoff Pol HE; Galvan A; Schnack HG; Steenhuis MP; Minderaa RB; Buitelaar JK; Kahn RS; van Engeland H
    Mol Psychiatry; 2005 Jul; 10(7):678-85. PubMed ID: 15724142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anger symptoms and "delinquent" behavior in Tourette syndrome with and without attention deficit hyperactivity disorder.
    Cavanna AE; Cavanna S; Monaco F
    Brain Dev; 2008 Apr; 30(4):308. PubMed ID: 17920219
    [No Abstract]   [Full Text] [Related]  

  • 38. Structural brain imaging of attention-deficit/hyperactivity disorder.
    Seidman LJ; Valera EM; Makris N
    Biol Psychiatry; 2005 Jun; 57(11):1263-72. PubMed ID: 15949998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interhemispheric callosal transfer in adults with attention-deficit/hyperactivity disorder: an event-related potential study.
    Rolfe MH; Kirk IJ; Waldie KE
    Neuroreport; 2007 Feb; 18(3):255-9. PubMed ID: 17314667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
    Wilens TE
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.